Each chewable tablet contains:
Montelukast Sodium USP
equivalent to Montelukast 5 mg.
INDICATIONS: Indicated for: • treatment of asthma as add-on therapy in those 6 to 14 years old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting β-agonists provide inadequate clinical control of asthma. • alternative treatment option to low-dose inhaled corticosteroids for 6 to 14 years old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids. • relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. • prophylaxis of asthma for 6 to 14 years old patients in which the predominant component is exercise-induced bronchoconstrictionPACKING: 6x10 Tablets